LURDES INOUE

Education

• PhDStatisticsDuke University
• MSStatisticsDuke University
• MSStatisticsUniversity of Sao Paulo (Brazil)
• BSStatisticsUniversity of Sao Paulo (Brazil)

Faculty Research

• Clinical Trials
• Longitudinal and Multilevel Data
• Bayesian Biostatistics
• Cancer Research
• Decision Theory

Publications

• 2016 Hubbard RA, Lange J, Zhang Y, Salim BA, Stroud JR, Inoue LY. Using semi-Markov processes to study timeliness and tests used in the diagnostic evaluation of suspected breast cancer. Statistics in Medicine. PMID 27439856 DOI: 10.1002/Sim.7055 0.44
  
• 2015 Hung HM, Inoue L, Pickering E. University of Pennsylvania 7th annual conference on statistical issues in clinical trials: Current issues regarding the use of biomarkers and surrogate endpoints in clinical trials (afternoon panel discussion session). Clinical Trials (London, England). 12: 365-73. PMID 26178573 DOI: 10.1177/1740774515590089 0.44
  
• 2015 Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, ... ... Inoue LY, et al. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circulation. Cardiovascular Quality and Outcomes. 8: 179-86. PMID 25669833 DOI: 10.1161/CIRCOUTCOMES.114.001306 0.44
  
• 2015 Lange JM, Hubbard RA, Inoue LY, Minin VN. A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data. Biometrics. 71: 90-101. PMID 25319319 DOI: 10.1111/Biom.12252 0.44
  
• 2014 Steinberg BA, Al-Khatib SM, Edwards R, Han J, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, ... ... Inoue LY, et al. Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. Jacc. Heart Failure. 2: 623-9. PMID 25306452 DOI: 10.1016/j.jchf.2014.06.007 0.44
  
• 2014 Agapova M, Devine EB, Nguyen H, Wolf FM, Inoue LY. Using indirect comparisons to compare interventions within a Cochrane review: a tool for comparative effectiveness research. Journal of Comparative Effectiveness Research. 3: 345-57. PMID 25275232 DOI: 10.2217/Cer.14.29 0.44
  
• 2014 Pun PH, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, ... ... Inoue LY, et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 64: 32-9. PMID 24518128 DOI: 10.1053/j.ajkd.2013.12.009 0.44
  
• 2014 Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, ... Inoue LY, et al. Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? International Journal of Cardiology. 172: 253-4. PMID 24467982 DOI: 10.1016/j.ijcard.2013.12.278 0.44
  
• 2014 Gulati R, Inoue LY, Gore JL, Katcher J, Etzioni R. Individualized estimates of overdiagnosis in screen-detected prostate cancer. Journal of the National Cancer Institute. 106: djt367. PMID 24399850 DOI: 10.1093/Jnci/Djt367 0.44
  
• 2014 Inoue LY, Trock BJ, Partin AW, Carter HB, Etzioni R. Modeling grade progression in an active surveillance study. Statistics in Medicine. 33: 930-9. PMID 24123208 DOI: 10.1002/Sim.6003 0.44
  
• 2013 Hess PL, Al-Khatib SM, Inoue LY, Sanders GD. When to implant an ICD following a myocardial infarction? Heart Rhythm : the Official Journal of the Heart Rhythm Society. 10: e79. PMID 23891957 DOI: 10.1016/j.hrthm.2013.07.035 0.44
  
• 2013 Hess PL, Laird A, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Hall WJ, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, ... ... Inoue LY, et al. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 10: 828-35. PMID 23416381 DOI: 10.1016/J.Hrthm.2013.02.011 0.44
  
• 2013 Inoue LYT, Gulati R, Yu C, Kattan MW, Etzioni R. Deriving benefit of early detection from biomarker-based prognostic models Biostatistics. 14: 15-27. PMID 22730510 DOI: 10.1093/Biostatistics/Kxs018 0.44
  
• 2012 Soine LA, Cunningham SL, Motzer SA, Inoue LY, Caldwell JH. Application of appropriate use criteria for stress myocardial perfusion imaging at two academic medical centers: compliance and association with image findings. Journal of the American Academy of Nurse Practitioners. 24: 200-8. PMID 22486835 DOI: 10.1111/J.1745-7599.2011.00679.X 0.44
  
• 2011 Gulati R, Wever EM, Tsodikov A, Penson DF, Inoue LY, Katcher J, Lee SY, Heijnsdijk EA, Draisma G, de Koning HJ, Etzioni R. What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 740-50. PMID 21546365 DOI: 10.1158/1055-9965.Epi-10-0718 0.44
  
• 2010 Gulati R, Inoue L, Katcher J, Hazelton W, Etzioni R. Calibrating disease progression models using population data: a critical precursor to policy development in cancer control. Biostatistics (Oxford, England). 11: 707-19. PMID 20530126 DOI: 10.1093/Biostatistics/Kxq036 0.44
  
• 2010 Parmigiani G, Inoue LYT, Lopes HF. Decision Theory: Principles and Approaches Decision Theory: Principles and Approaches. 1-372. DOI: 10.1002/9780470746684 0.44
  
• 2009 Hubbard RA, Inoue LY, Diehr P. Joint modeling of self-rated health and changes in physical functioning. Journal of the American Statistical Association. 104: 912. PMID 20151036 DOI: 10.1198/Jasa.2009.Ap08423 0.44
  
• 2009 Telesca D, Inoue LY, Neira M, Etzioni R, Gleave M, Nelson C. Differential expression and network inferences through functional data modeling. Biometrics. 65: 793-804. PMID 19053995 DOI: 10.1111/J.1541-0420.2008.01159.X 0.44
  
• 2008 Inoue LY, Etzioni R, Morrell C, Müller P. Modeling Disease Progression with Longitudinal Markers. Journal of the American Statistical Association. 103: 259-270. PMID 24453387 DOI: 10.1198/016214507000000356 0.44
  
• 2008 Hubbard RA, Inoue LY, Fann JR. Modeling nonhomogeneous Markov processes via time transformation. Biometrics. 64: 843-50. PMID 18047532 DOI: 10.1111/J.1541-0420.2007.00932.X 0.44
  
• 2008 Telesca D, Inoue LYT. Bayesian hierarchical curve registration Journal of the American Statistical Association. 103: 328-339. DOI: 10.1198/016214507000001139 0.44
  
• 2007 Etzioni RD, Ankerst DP, Weiss NS, Inoue LY, Thompson IM. Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence. Journal of the National Cancer Institute. 99: 1510-5. PMID 17925534 DOI: 10.1093/jnci/djm171 0.44
  
• 2007 Inoue LY, Neira M, Nelson C, Gleave M, Etzioni R. Cluster-based network model for time-course gene expression data. Biostatistics (Oxford, England). 8: 507-25. PMID 16980695 DOI: 10.1093/Biostatistics/Kxl026 0.44
  
• 2007 Thall PF, Cheung YK, Inoue LYT, Wathen JK. Comments on 'Continuous Bayesian adaptive randomization based on event times with covariates' [4] Statistics in Medicine. 26: 3052-3054. DOI: 10.1002/Sim.2762 0.44
  
• 2006 Berry DA, Inoue L, Shen Y, Venier J, Cohen D, Bondy M, Theriault R, Munsell MF. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. Journal of the National Cancer Institute. Monographs. 30-6. PMID 17032892 DOI: 10.1093/Jncimonographs/Lgj006 0.44
  
• 2006 Cheung YK, Inoue LY, Wathen JK, Thall PF. Continuous Bayesian adaptive randomization based on event times with covariates. Statistics in Medicine. 25: 55-70. PMID 16025549 DOI: 10.1002/Sim.2247 0.44
  
• 2005 Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. Journal of the National Cancer Institute. 97: 1195-203. PMID 16106024 DOI: 10.1093/Jnci/Dji239 0.44
  
• 2005 Inoue LYT, Berry DA, Parmigiani G. Relationship between bayesian and frequentist sample size determination American Statistician. 59: 79-87. DOI: 10.1198/000313005X21069 0.44
  
• 2005 Carlin B, Louis TA, Inoue LYT, Ashby D, Tan SB. Where's the utility in Bayesian data-monitoring of clinical trials?: Comment Clinical Trials. 2: 205-208.